R Valgardsdottir
Overview
Explore the profile of R Valgardsdottir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Capelli C, Pedrini O, Valgardsdottir R, Da Roit F, Golay J, Introna M
Immunol Lett
. 2015 Jun;
168(2):222-7.
PMID: 26092523
Producing advanced therapy medicinal products (ATMP) according to Good Manufacturing Practice (GMP) guidelines represents a global challenge for the expansion of cells intended for human use. Mesenchymal stromal cells (MSCs)...
2.
Valgardsdottir R, Brede G, Eide L, Frengen E, Prydz H
J Biol Chem
. 2001 May;
276(34):32056-63.
PMID: 11350955
A cDNA encoding a novel member of the helicase family, MDDX28, has been cloned from a human testis library. This apparently intronless gene was transcribed in all tissues studied. MDDX28...
3.
van Slooten H, van de Vijver M, Borresen A, Eyfjord J, Valgardsdottir R, Scherneck S, et al.
J Pathol
. 2000 Jan;
189(4):504-13.
PMID: 10629550
In breast cancer, mutations located in the zinc-binding functional domains of the p53 gene have been reported to predict a worse prognosis and a worse response to treatment with doxorubicin,...
4.
Gretarsdottir S, Thorlacius S, Valgardsdottir R, Gudlaugsdottir S, Sigurdsson S, Steinarsdottir M, et al.
Cancer Res
. 1998 Mar;
58(5):859-62.
PMID: 9500438
The products of the BRCA breast cancer susceptibility genes have been implicated in cell cycle control and DNA repair. It has been suggested that mutations in the p53 gene are...
5.
Valgardsdottir R, Tryggvadottir L, Steinarsdottir M, Olafsdottir K, Jonasdottir S, Jonasson J, et al.
APMIS
. 1997 Feb;
105(2):121-30.
PMID: 9113074
Alterations of the TP53 gene were analyzed in samples from 87 primary breast cancer patients, using molecular and immunohistochemical approaches. Mutations were detected in 17% of the samples, using polymerase...
6.
Valgardsdottir R, Steinarsdottir M, Anamthawat-Jonsson K, Petursdottir I, Ogmundsdottir H, Eyfjord J
Cancer Genet Cytogenet
. 1996 Nov;
92(1):37-42.
PMID: 8956869
Molecular genetics and cytogenetics are two different approaches to studying genetic changes in breast carcinoma. We have used karyotype analysis, fluorescence in situ hybridization, and molecular analysis of allelic imbalance...
7.
Eyfjord J, Thorlacius S, Steinarsdottir M, Valgardsdottir R, Ogmundsdottir H, Anamthawat-Jonsson K
Cancer Res
. 1995 Feb;
55(3):646-51.
PMID: 7530599
Abnormalities in the p53 tumor suppressor gene have been shown to affect cell cycle control and lead to genetic instability in cell lines of murine and human origin. We have...
8.
Eyfjord J, Thorlacius S, Valgardsdottir R, Gretarsdottir S, Steinarsdottir M, Anamthawat-Jonsson K
Acta Oncol
. 1995 Jan;
34(5):663-7.
PMID: 7546836
TP53 abnormalities in breast carcinomas and inherited TP53 changes in breast cancer patients and in Li-Fraumeni-like families were looked for. Tumours were screened for mutations in the TP53 gene by...